ID   GLT14_HUMAN             Reviewed;         552 AA.
AC   Q96FL9; B3KV89; Q4ZG75; Q53SU1; Q53TJ0; Q8IVI4; Q9BRH1; Q9H827;
AC   Q9H9J8;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   15-MAR-2017, entry version 139.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 14;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 14;
DE            Short=GalNAc-T14;
DE            Short=pp-GaNTase 14;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 14;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14;
GN   Name=GALNT14; ORFNames=UNQ2434/PRO4994;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY, ALTERNATIVE
RP   SPLICING, AND TISSUE SPECIFICITY.
RC   TISSUE=Stomach;
RX   PubMed=12507512; DOI=10.1016/S0006-291X(02)02908-X;
RA   Wang H., Tachibana K., Zhang Y., Iwasaki H., Kameyama A., Chen L.,
RA   Guo J.-M., Hiruma T., Togayachi A., Kudo T., Kikuchi N., Narimatsu H.;
RT   "Cloning and characterization of a novel UDP-GalNAc:polypeptide N-
RT   acetylgalactosaminyltransferase, pp-GalNAc-T14.";
RL   Biochem. Biophys. Res. Commun. 300:738-744(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wandall H.H., Bennett E.P.;
RL   Submitted (SEP-2011) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-435 (ISOFORM 2).
RC   TISSUE=Fibroblast, Retinoblastoma, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=20179215; DOI=10.1158/1078-0432.CCR-09-3108;
RA   Stern H.M., Padilla M., Wagner K., Amler L., Ashkenazi A.;
RT   "Development of immunohistochemistry assays to assess GALNT14 and
RT   FUT3/6 in clinical trials of dulanermin and drozitumab.";
RL   Clin. Cancer Res. 16:1587-1596(2010).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked
CC       oligosaccharide biosynthesis, the transfer of an N-acetyl-D-
CC       galactosamine residue to a serine or threonine residue on the
CC       protein receptor. Displays activity toward mucin-derived peptide
CC       substrates such as Muc2, Muc5AC, Muc7, and Muc13 (-58). May be
CC       involved in O-glycosylation in kidney.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine +
CC       polypeptide = UDP + N-acetyl-alpha-D-galactosaminyl-polypeptide.
CC       {ECO:0000269|PubMed:12507512}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q96FL9-1; Sequence=Displayed;
CC         Note=Major isoform.;
CC       Name=2;
CC         IsoId=Q96FL9-2; Sequence=VSP_011222;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q96FL9-3; Sequence=VSP_011221;
CC         Note=Minor isoform.;
CC       Name=4;
CC         IsoId=Q96FL9-4; Sequence=VSP_045121;
CC   -!- TISSUE SPECIFICITY: Detected in renal tubules (at protein level).
CC       Highly expressed in fetal and adult kidney. Widely expressed at
CC       low level. Weakly expressed in whole brain, cerebellum, thymus,
CC       lung, mammary gland, liver, stomach, small intestine, colon,
CC       pancreas, spleen, bladder, uterus, placenta, testis, ovary,
CC       skeletal muscle, leukocyte, B-cell, bone marrow, fetal brain,
CC       fetal thymus, fetal lung, fetal liver, fetal small intestine,
CC       fetal spleen, fetal skeletal and fetus. Detected in renal tubules
CC       (at protein level). {ECO:0000269|PubMed:12507512,
CC       ECO:0000269|PubMed:20179215}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif),
CC       which is probably involved in manganese coordination and substrate
CC       binding and the C-terminal domain (domain B, also called
CC       Gal/GalNAc-T motif), which is probably involved in catalytic
CC       reaction and UDP-Gal binding. {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and
CC       contributes to the glycopeptide specificity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14795.1; Type=Miscellaneous discrepancy; Note=Chimeric at the C-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 14;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_497";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB078144; BAC56889.1; -; mRNA.
DR   EMBL; Y09324; CAA70505.4; -; mRNA.
DR   EMBL; AY358758; AAQ89118.1; -; mRNA.
DR   EMBL; AK022753; BAB14227.1; -; mRNA.
DR   EMBL; AK024039; BAB14795.1; ALT_SEQ; mRNA.
DR   EMBL; AK091313; BAC03634.1; -; mRNA.
DR   EMBL; AK122747; BAG53701.1; -; mRNA.
DR   EMBL; AC009301; AAX88899.1; -; Genomic_DNA.
DR   EMBL; AC009305; AAX93209.1; -; Genomic_DNA.
DR   EMBL; AC015980; AAY24301.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00489.1; -; Genomic_DNA.
DR   EMBL; BC006269; AAH06269.2; -; mRNA.
DR   EMBL; BC010659; AAH10659.1; -; mRNA.
DR   CCDS; CCDS1773.2; -. [Q96FL9-1]
DR   CCDS; CCDS58705.1; -. [Q96FL9-4]
DR   CCDS; CCDS58706.1; -. [Q96FL9-3]
DR   RefSeq; NP_001240755.1; NM_001253826.1. [Q96FL9-3]
DR   RefSeq; NP_001240756.1; NM_001253827.1. [Q96FL9-4]
DR   RefSeq; NP_001316024.1; NM_001329095.1.
DR   RefSeq; NP_001316025.1; NM_001329096.1. [Q96FL9-4]
DR   RefSeq; NP_078848.2; NM_024572.3. [Q96FL9-1]
DR   UniGene; Hs.468058; -.
DR   UniGene; Hs.733100; -.
DR   ProteinModelPortal; Q96FL9; -.
DR   SMR; Q96FL9; -.
DR   BioGrid; 122753; 4.
DR   STRING; 9606.ENSP00000288988; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   iPTMnet; Q96FL9; -.
DR   PhosphoSitePlus; Q96FL9; -.
DR   BioMuta; GALNT14; -.
DR   DMDM; 51316071; -.
DR   MaxQB; Q96FL9; -.
DR   PaxDb; Q96FL9; -.
DR   PeptideAtlas; Q96FL9; -.
DR   PRIDE; Q96FL9; -.
DR   DNASU; 79623; -.
DR   Ensembl; ENST00000324589; ENSP00000314500; ENSG00000158089. [Q96FL9-3]
DR   Ensembl; ENST00000349752; ENSP00000288988; ENSG00000158089. [Q96FL9-1]
DR   Ensembl; ENST00000406653; ENSP00000385435; ENSG00000158089. [Q96FL9-4]
DR   GeneID; 79623; -.
DR   KEGG; hsa:79623; -.
DR   UCSC; uc002rnq.4; human. [Q96FL9-1]
DR   CTD; 79623; -.
DR   DisGeNET; 79623; -.
DR   GeneCards; GALNT14; -.
DR   HGNC; HGNC:22946; GALNT14.
DR   HPA; HPA030138; -.
DR   MIM; 608225; gene.
DR   neXtProt; NX_Q96FL9; -.
DR   OpenTargets; ENSG00000158089; -.
DR   PharmGKB; PA134920089; -.
DR   eggNOG; KOG3738; Eukaryota.
DR   eggNOG; ENOG410XPRX; LUCA.
DR   GeneTree; ENSGT00760000118828; -.
DR   HOVERGEN; HBG051699; -.
DR   InParanoid; Q96FL9; -.
DR   KO; K00710; -.
DR   OMA; DWDDLWD; -.
DR   OrthoDB; EOG091G085O; -.
DR   PhylomeDB; Q96FL9; -.
DR   TreeFam; TF313267; -.
DR   BRENDA; 2.4.1.41; 2681.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; GALNT14; human.
DR   GeneWiki; GALNT14; -.
DR   GenomeRNAi; 79623; -.
DR   PRO; PR:Q96FL9; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000158089; -.
DR   CleanEx; HS_GALNT14; -.
DR   ExpressionAtlas; Q96FL9; baseline and differential.
DR   Genevisible; Q96FL9; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; TAS:Reactome.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycosyltransferase; Golgi apparatus; Lectin; Manganese; Membrane;
KW   Metal-binding; Polymorphism; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    552       Polypeptide N-
FT                                acetylgalactosaminyltransferase 14.
FT                                /FTId=PRO_0000059133.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     26       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     27    552       Lumenal. {ECO:0000255}.
FT   DOMAIN      415    550       Ricin B-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   REGION      110    215       Catalytic subdomain A.
FT   REGION      274    336       Catalytic subdomain B.
FT   METAL       199    199       Manganese. {ECO:0000250}.
FT   METAL       201    201       Manganese. {ECO:0000250}.
FT   METAL       333    333       Manganese. {ECO:0000250}.
FT   BINDING     151    151       Substrate. {ECO:0000250}.
FT   BINDING     176    176       Substrate. {ECO:0000250}.
FT   BINDING     200    200       Substrate. {ECO:0000250}.
FT   BINDING     305    305       Substrate. {ECO:0000250}.
FT   BINDING     336    336       Substrate. {ECO:0000250}.
FT   BINDING     339    339       Substrate. {ECO:0000250}.
FT   BINDING     341    341       Substrate. {ECO:0000250}.
FT   DISULFID    101    328       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    319    397       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    430    449       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    476    493       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    517    538       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   VAR_SEQ       1     43       MRRLTRRLVLPVFGVLWITVLLFFWVTKRKLEVPTGPEVQT
FT                                PK -> MSFPMSLARSSVPFADSGLSSSQ (in isoform
FT                                4). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045121.
FT   VAR_SEQ      44     99       PSDADWDDLWDQFDERRYLNAKKWRVGDDPYKLYAFNQRES
FT                                ERISSNRAIPDTRHL -> VWSLFFKVAGMSPWAPQVPVSP
FT                                TPPYQRGHLPTGGHLAVCHFPCLLQEAQFHLQTQVFLQV
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_011221.
FT   VAR_SEQ     100    132       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_011222.
FT   VARIANT     469    469       Q -> K (in dbSNP:rs2288101).
FT                                /FTId=VAR_033948.
FT   CONFLICT    368    368       Q -> R (in Ref. 4; BAB14795).
FT                                {ECO:0000305}.
SQ   SEQUENCE   552 AA;  64321 MW;  6F2ABAA89F482696 CRC64;
     MRRLTRRLVL PVFGVLWITV LLFFWVTKRK LEVPTGPEVQ TPKPSDADWD DLWDQFDERR
     YLNAKKWRVG DDPYKLYAFN QRESERISSN RAIPDTRHLR CTLLVYCTDL PPTSIIITFH
     NEARSTLLRT IRSVLNRTPT HLIREIILVD DFSNDPDDCK QLIKLPKVKC LRNNERQGLV
     RSRIRGADIA QGTTLTFLDS HCEVNRDWLQ PLLHRVKEDY TRVVCPVIDI INLDTFTYIE
     SASELRGGFD WSLHFQWEQL SPEQKARRLD PTEPIRTPII AGGLFVIDKA WFDYLGKYDM
     DMDIWGGENF EISFRVWMCG GSLEIVPCSR VGHVFRKKHP YVFPDGNANT YIKNTKRTAE
     VWMDEYKQYY YAARPFALER PFGNVESRLD LRKNLRCQSF KWYLENIYPE LSIPKESSIQ
     KGNIRQRQKC LESQRQNNQE TPNLKLSPCA KVKGEDAKSQ VWAFTYTQQI LQEELCLSVI
     TLFPGAPVVL VLCKNGDDRQ QWTKTGSHIE HIASHLCLDT DMFGDGTENG KEIVVNPCES
     SLMSQHWDMV SS
//
